Group 1: Investor Relations Activities - The company engaged in investor relations activities through the "Investor Relations Interactive Platform" on September 12, 2024 [1][3] - The event included participation from key executives: Chairman Lv Bin, General Manager Lu Bin, and CFO Li Keya [3] Group 2: Project Updates - The "Warehouse Logistics Center Project" covers a total area of 114,701.63 square meters, with a construction period of 36 months [4] - As of the report date, the project is 32.74% complete and is expected to be operational by March 2026 [4] Group 3: Financial Management - The company has a bad debt provision ratio of 5%, based on risk assessment and expected credit loss models [4] - Accounts receivable primarily come from the operation of medium to large brands, with a collection period of 1 to 3 months post-invoice [4][8] Group 4: Subsidiary Management - The company holds over 50% but less than 100% of shares in several subsidiaries, which may affect control and decision-making [5] - Non-wholly owned subsidiaries are managed under a centralized governance structure to protect shareholder interests [5][8] Group 5: Strategic Investments - Investments in joint ventures like Yuanmei Bio and Fenjie International align with the company's strategic focus on health consumer products [6] - The brand incubation and management business is seen as a second growth line for the company [7] Group 6: Risk Management - The company has established a comprehensive system for managing accounts receivable, including clear payment terms and regular follow-ups [8] - The management approach includes aging analysis and risk evaluation to mitigate potential bad debt risks [8]
青木股份(301110) - 2024年9月12日投资者关系活动记录表